Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial

Annals of Neurology,Volume 0, Issue ja, -Not available-.

Source: Annals of Neurology - August 29, 2018 Category: Neurology Authors: Jerry S. Wolinsky MD , Xavier Montalban MD, PhD , Stephen L. Hauser MD , Gavin Giovannoni MBBCh, PhD, FCP , Patrick Vermersch MD, PhD , Corrado Bernasconi MD, PhD , Gurpreet Deol ‐Bhullar BS , Hideki Garren MD, PhD , Pet Source Type: research